your search results
Simply choose your interests by category and year. You can reduce your result list by deactivating categories you are not interested in.
- Articles in the press
- News
- Press releases
- Company news
Safety Meets Accessibility: Creating the Ideal Packaging for On-The-Go Dosage Forms
Our innovative stick packs combine child-resistant safety with senior-friendly accessibility. Engineered for modern patient needs, they enable precise, fast and water-free medication intake while preventing accidental openings. Read how our new laser-cut design meets international safety standards while ensuring convenience without compromise – article published in Contract Pharma.
Effervescent Evolution: New Technologies and Method Revitalize a Time-Tested Dosage Form
We have introduced a new advancement in effervescent tablet manufacturing. The patented manufacturing method not only enhances production efficiency, but also delivers excellent palatability while reducing environmental impact. The secured patent protection underscores HERMES PHARMA’s commitment to refining pharmaceutical delivery solutions while ensuring product exclusivity. Article published by Tablets & Capsules.
HERMES PHARMA Receives Recognition for Research Excellence from German Government
HERMES PHARMA has been awarded the BSFZ seal from the German Certification Office for Research Allowance. This recognition underscores our contributions to innovation in pharmaceutical manufacturing as well as our commitment to advancing healthcare solutions that benefit all – industry partners, patients and consumers.
Reducing Risk, Speeding Development — a CDMO Model Including GCP-Sponsorship to Better Meet the Needs of Pharma Companies
Pharmaceutical companies are under mounting pressure to develop more user-friendly products. Faced with fierce competition, they’re also demanding more CDMO support than ever. How does a new type of CDMO offering — one that takes on the responsibility of clinical trial sponsorship — de-risk and accelerate go-to-market? Read this Q&A with Drug Development & Delivery.
HERMES PHARMA announces €25 million investment to bolster capacity
The investment will help HERMES PHARMA to meet the soaring demand for the development and manufacturing of its user-friendly dosage forms. The new equipment, increased storage and production capacities will increase operational efficiency. As a result, the company will be able to further drive future growth, while helping new and existing customers to realize theirs.
HERMES PHARMA Again Achieves Silver CSR Award from EcoVadis
EcoVadis is one of the leading and most trusted provider of business sustainability ratings. The silver medal acknowledges HERMES PHARMA’s continued commitment to sustainable and responsible practices and was awarded on the back of a rigorous review of the company’s business operations.